(E)-3-(aryl(arylamino)methylene)indolin-2-one derivatives: An efficient synthetic approach and evaluation of their cancer inhibitory activity

  • Journal of Chemical Research, January 2018, Science Reviews 2000 LTD
  • DOI: 10.3184/174751918x15210371652644
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: